You will support investment decision making and portfolio construction using internal and external sources of data and research.
Border to Coast are now seeking an Assistant Portfolio Manager to assist in the preparation and maintenance of extensive due diligence reports.
Performing ongoing monitoring of existing managers and underlying strategies, including co-ordination of process, you will identify risks in all areas of the business and notify any such risks to your People Manager and the Operational Risk Manager.
Position Overview: Reed are proud to be working a leading institution in clinical research in their search for junior doctors to assist in a clinical trial.
The trial seeks to investigate the effect of oral semaglutide vs. placebo on cardiovascular outcomes in up to 20,000 participants with type 2 diabetes.
Participants take part remotely (by completing questionnaires on their own device or during telephone interviews with research nurses) and study treatment is sent to their homes by post.
Posted by IDEX Consulting Ltd • £50K/yr to £65K/yr
An Account Executive who is about to take over a book of business will always have the same worry; "after 12 months, this book is going to be heavily under attack"....and trust me, it's completely natural to have that concern.
But, what if I told you I'm working with a Broker in Leeds who have a book ready to go with 0% chance of it being under threat?
A big player in the Leeds market has a book of c£200k income ready to go from an individual who is retiring.
If you have experience in conducting risk analysis, AML checks, resolving escalated conflicts and become a point of contact on all client onboarding queries we want to hear from you!
We are working with our client to recruit an individual with attention to detail and diligence to join their Risk and Compliance team.
To be considered for the role, you'll require the following essentials:
About the Trial: Our Client is conducting a significant clinical trial to investigate the effects of oral semaglutide versus placebo on cardiovascular outcomes in up to 20,000 participants with type 2 diabetes.
Study treatments will be sent to participants' homes by post.
Participants will take part remotely by completing questionnaires on their own devices or during telephone interviews with research nurses.